QIHU [Qihoo 360 Technology Co] 6-K: (Original Filing)

[Qihoo 360 Technology Co. Ltd. Announces Closing of Offering of US$900 Million of Convertible Senior Notes The notes are convertible into Qihoo 360's American Depositary Shares ("ADSs"), every two ADSs representing as of the date above three Class A ordinary shares of Qihoo 360, based on an initial conversion rate of 7.9789 ADSs per US$1,000 principal amount of the 2020] []

By | 2016-03-14T00:06:14+00:00 August 6th, 2014|Categories: Chinese Stocks, QIHU, SEC Original|Tags: , , , , , |0 Comments

DSKY [iDreamSky Technology] EFFECT: (Original Filing)

[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif} .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif} .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif} .FormText {font-size: x-small; font-family: arial, helvetica, sans-serif} .SmallFormText {font-size: xx-small; font-family: arial, helvetica, sans-serif} .FormTitle {font-size: medium; font-family: arial, helvetica, sans-serif; font-weight: bold} .FormName {font-size: large; font-family: arial, helvetica, sans-serif;]

By | 2016-03-16T23:01:09+00:00 August 6th, 2014|Categories: Chinese Stocks, DSKY, SEC Original|Tags: , , , , , |0 Comments

BABA [Alibaba] CORRESP: (Original Filing)

[IMPSON HACHER ARTLETT S OWER TH LOOR ICBC T ARDEN OAD 3 G ONG ONG H (852) 2514-7600 ACSIMILE F IRECT IAL UMBER D +852-2514-7630 AIL DDRESS E-M lchen@stblaw.com Aug 6, 2014 VIA EDGAR 100 F Street, N.E. Attention: Ms. Mara L. Ransom, Assistant Director Ms. Jennifer Thompson, Accounting Branch Chief Mr. Dietrich King, Legal Branch Chief Ms. Lisa Kohl,]

By | 2016-03-17T22:01:28+00:00 August 6th, 2014|Categories: BABA, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

CBPO [China Biologic Products] 8-K: (Original Filing)

[FOR RELEASE August 5, 2014 China Biologic Reports Financial Results for the Second Quarter of 2014 2Q14 Total Sales Increase 12.1% to $60.1Million 2Q14 Operating Margin Increases to 48.1% from 2Q14 Non-GAAP Net Income Increases 17.9% to $20.5 Million BEIJING, China – August 5, 2014 – Second Quarter 2014 Financial Highlights · Total sales · Gross profit · Income from] []

CBPO [China Biologic Products] 10-Q: (Original Filing)

[] [STATE OF DELAWARE SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF CHINA BIOLOGIC PRODUCTS, INC. Corporation China Biologic Products, Inc., a corporation organized and existing under the laws of the State of Delaware (the “ A. The name of the Corporation is China Biologic Products, Inc. The original Certificate of Incorporation of the Corporation was filed with the Secretary of] [THIRD AMENDED AND RESTATED BYLAWS OF CHINA BIOLOGIC PRODUCTS, INC. (the “Corporation”) Adopted on June 20, 2014 ARTICLE I OFFICES Registered Office Certificate of Incorporation Section 1.01. Other Offices Board of Directors Board Section 1.02. ARTICLE II MEETINGS OF STOCKHOLDERS Annual Meeting Section 2.01. Voting List Section 2.02. Special Meeting Section 2.03. Advance Notice Procedures Section 2.04. Advance Notice of] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th David (Xiaoying) Gao Chief Executive Officer] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th Ming Yang Chief Financial Officer (Principal Financial Officer)]

KANG [iKang Healthcare] 6-K: (Original Filing)

[Press Release iKang Board of Directors Names Qing Liu as Independent Director BEIJING, August 1, 2014 (GLOBE NEWSWIRE) — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), the largest provider in China’s fast growing private preventive healthcare services market in terms of revenue in 2013, today announced that its Board of Directors has named Ms. Qing Liu as] [FORM 6-K IKANG HEALTHCARE GROUP, INC. B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing 100022 People’s Republic of China Form 20-F x Form 40-F o o o IKANG HEALTHCARE GROUP, INC.]

Skip to toolbar